Your browser doesn't support javascript.
loading
Intellectual property and funding: fueling Chinese synbio.
Liao, Lijuan; Lou, Yi; Tang, Xianming; Deng, Zixin; Gao, Jiangtao.
Afiliación
  • Liao L; Key Laboratory of Biopesticide and Chemical Biology of Ministry of Education, College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
  • Lou Y; Key Laboratory of Biopesticide and Chemical Biology of Ministry of Education, College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
  • Tang X; Key Laboratory of Biopesticide and Chemical Biology of Ministry of Education, College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
  • Deng Z; State Key Laboratory of Microbial Metabolism, Joint International Laboratory on Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.
  • Gao J; Key Laboratory of Biopesticide and Chemical Biology of Ministry of Education, College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China. Electronic address: jgaotao@gmail.com.
Trends Biotechnol ; 42(3): 258-260, 2024 03.
Article en En | MEDLINE | ID: mdl-37980185
As China emerges as a synthetic biology (synbio) global leader, it faces distinct science-society challenges. Our series offers a snapshot of China's synbio state, emphasizing the intersection and its policy implications. The debut piece elucidates the intellectual property rights (IPR)-funding interplay in China's expanding synbio territory, underlining its key role in driving innovation and commercialization.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Propiedad Intelectual / Biología Sintética País/Región como asunto: Asia Idioma: En Revista: Trends Biotechnol Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Propiedad Intelectual / Biología Sintética País/Región como asunto: Asia Idioma: En Revista: Trends Biotechnol Año: 2024 Tipo del documento: Article País de afiliación: China